Skip to content

Clinical trials

Phase 3 Cardiovascular Diseases trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiovascular Diseases Phase: Phase 3 Country / region: Russia Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20062
20082
20095
20101
20113
20124
20132
20141
20161
20171
20182
20191
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19
Terminated8
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline4
Takeda4
Novartis Pharmaceuticals3
AstraZeneca2
Eli Lilly and Company2
Pfizer2
Amarin Pharma Inc.1
Amgen1
CSL Behring1
Cardium Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiovascular Diseases28
Stroke8
Heart Diseases7
Myocardial Infarction7
Acute Coronary Syndrome5
Hypertension5
Vascular Diseases5
Diabetes Mellitus, Type 24
Heart Failure4
Atherosclerosis3

Trials

Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.